Literature DB >> 17675522

Cellular and humoral autoreactivity in idiopathic pulmonary fibrosis.

Carol A Feghali-Bostwick1, Christopher G Tsai, Vincent G Valentine, Stephen Kantrow, Michael W Stoner, Joseph M Pilewski, Aneal Gadgil, M Patricia George, Kevin F Gibson, Augustine M K Choi, Naftali Kaminski, Yingze Zhang, Steven R Duncan.   

Abstract

Idiopathic pulmonary fibrosis (IPF) is a morbid, refractory lung disorder with an unknown pathogenesis. To investigate potential adaptive immune mechanisms in IPF, we compared phenotypes and effector functions of peripheral CD4 T cells, autoantibody production, and proliferative responses of pulmonary hilar lymph node CD4 T cells to autologous lung extracts from afflicted patients and normals. Our results show that greater proportions of peripheral CD4 T lymphocytes in IPF subjects expressed MHC class II and CD154 (CD40L), and they more frequently elaborated TGF-beta1, IL-10, and TNF-alpha. Abnormal CD4 T cell clonal expansions were found in all IPF patients, and 82% of these subjects also had IgG autoantibodies against cellular Ags. IPF lung extracts stimulated proliferations of autologous CD4 T cells, unlike preparations from normals or those with other lung diseases, and the IPF proliferative responses were enhanced by repeated cycles of stimulation. Thus, CD4 T cells from IPF patients have characteristics typical of cell-mediated pathologic responses, including augmented effector functions, provision of facultative help for autoantibody production, oligoclonal expansions, and proliferations driven by an Ag present in diseased tissues. Recognition that an autoreactive immune process is present in IPF can productively focus efforts toward identifying the responsible Ag, and implementing more effective therapies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17675522     DOI: 10.4049/jimmunol.179.4.2592

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  67 in total

Review 1.  Fibrosis: ultimate and proximate causes.

Authors:  Victor J Thannickal; Yong Zhou; Amit Gaggar; Steven R Duncan
Journal:  J Clin Invest       Date:  2014-11-03       Impact factor: 14.808

Review 2.  Idiopathic pulmonary fibrosis-an epidemiological and pathological review.

Authors:  Andrea T Borchers; Christopher Chang; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2011-04       Impact factor: 8.667

3.  CD70 Activation Decreases Pulmonary Fibroblast Production of Extracellular Matrix Proteins.

Authors:  Thi K Tran-Nguyen; Jianmin Xue; Carol Feghali-Bostwick; Frank C Sciurba; Daniel J Kass; Steven R Duncan
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

Review 4.  Idiopathic pulmonary fibrosis and a role for autoimmunity.

Authors:  Gerard F Hoyne; Hannah Elliott; Steven E Mutsaers; Cecilia M Prêle
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

Review 5.  Epigenomics of idiopathic pulmonary fibrosis.

Authors:  Ivana V Yang
Journal:  Epigenomics       Date:  2012-04       Impact factor: 4.778

6.  Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation.

Authors:  Vaidehi Kaza; Chengsong Zhu; Leying Feng; Fernando Torres; Srinivas Bollineni; Manish Mohanka; Amit Banga; John Joerns; T Mohanakumar; Lance S Terada; Quan-Zhen Li
Journal:  Transpl Immunol       Date:  2020-01-30       Impact factor: 1.708

7.  Retinoic acid-related orphan receptor-α is induced in the setting of DNA damage and promotes pulmonary emphysema.

Authors:  Ying Shi; Jiaofei Cao; Jane Gao; Liang Zheng; Andrew Goodwin; Chang Hyoek An; Avignat Patel; Janet S Lee; Steven R Duncan; Naftali Kaminski; Kusum V Pandit; Ivan O Rosas; Augustine M K Choi; Danielle Morse
Journal:  Am J Respir Crit Care Med       Date:  2012-06-28       Impact factor: 21.405

8.  Regulatory T Cells in Idiopathic Pulmonary Fibrosis: Too Much of a Good Thing?

Authors:  Meagan W Moore; Erica L Herzog
Journal:  Am J Pathol       Date:  2016-06-23       Impact factor: 4.307

9.  CD28 down-regulation on circulating CD4 T-cells is associated with poor prognoses of patients with idiopathic pulmonary fibrosis.

Authors:  Syed R Gilani; Louis J Vuga; Kathleen O Lindell; Kevin F Gibson; Jianmin Xue; Naftali Kaminski; Vincent G Valentine; Emily K Lindsay; M Patricia George; Chad Steele; Steven R Duncan
Journal:  PLoS One       Date:  2010-01-29       Impact factor: 3.240

Review 10.  Viruses in Idiopathic Pulmonary Fibrosis. Etiology and Exacerbation.

Authors:  Bethany B Moore; Thomas A Moore
Journal:  Ann Am Thorac Soc       Date:  2015-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.